Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase III DeLLphi-304 study.

Rudin CM, Ahn MJ, Schuler M, Blackhall FH, Mountzios G, Yoshida T, Sun L, Cho BC, Lugini A, Arulananda S, Punekar SR, Rocha P, Paz-Ares L, Mazières J, Gümüş M, Demirci U, Huang S, Abidi B, Patil U, Zhu B

Open source

DOI
10.1016/j.annonc.2026.10.095
Published
2026 Oct 26
Container
Annals of oncology : official journal of the European Society for Medical Oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.annonc.2026.10.095,
  title = {Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase III DeLLphi-304 study.},
  author = {Rudin CM and Ahn MJ and Schuler M and Blackhall FH and Mountzios G and Yoshida T and Sun L and Cho BC and Lugini A and Arulananda S and Punekar SR and Rocha P and Paz-Ares L and Mazières J and Gümüş M and Demirci U and Huang S and Abidi B and Patil U and Zhu B},
  year = {2026},
  journal = {Annals of oncology : official journal of the European Society for Medical Oncology},
  doi = {10.1016/j.annonc.2026.10.095},
  url = {https://doi.org/10.1016/j.annonc.2026.10.095}
}

RIS

TY  - JOUR
TI  - Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase III DeLLphi-304 study.
AU  - Rudin CM
AU  - Ahn MJ
AU  - Schuler M
AU  - Blackhall FH
AU  - Mountzios G
AU  - Yoshida T
AU  - Sun L
AU  - Cho BC
AU  - Lugini A
AU  - Arulananda S
AU  - Punekar SR
AU  - Rocha P
AU  - Paz-Ares L
AU  - Mazières J
AU  - Gümüş M
AU  - Demirci U
AU  - Huang S
AU  - Abidi B
AU  - Patil U
AU  - Zhu B
PY  - 2026
JO  - Annals of oncology : official journal of the European Society for Medical Oncology
DO  - 10.1016/j.annonc.2026.10.095
UR  - https://doi.org/10.1016/j.annonc.2026.10.095
ER  - 

APA

CM, R., MJ, A., M, S., FH, B., G, M., T, Y., L, S., BC, C., A, L., S, A., SR, P., P, R., L, P., J, M., M, G., U, D., S, H., B, A., U, P., & B, Z. (2026). Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase III DeLLphi-304 study.. Annals of oncology : official journal of the European Society for Medical Oncology. https://doi.org/10.1016/j.annonc.2026.10.095

Source records